Patent · US Active

Immunosuppressive Tat derivative polypeptides

US9878001B2 · kind B2 · utility

0Cited by

5References

7Claims

0Family size

Assignee

PIN Pharma, Inc. · US

Inventors

Joshua Goldberg · New York, US
Colin Bier · New York, US
Christoph Hotz-Behofsits · New York, US
Sophie Hanscom · New York, US

Key dates

Filing date	Dec 6, 2013
Grant date	Jan 30, 2018
Priority date	—
Expiry date	Dec 6, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present specification provides immunosuppressive Tat derivative polypeptides, compositions, and methods of using such polypeptides and compositions to treat an autoimmune disease, an inflammation-associated disease and/or a neurodegenerative disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.